Correction: Enhancement of oral bioavailability of ibrutinib using a liposil nanohybrid delivery system.

Where this comes from

• Record sourced from PubMed, PMID 39661590.
• Also identified by DOI 10.1371/journal.pone.0315777 and PMC identifier 11633945.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.